| MeSH term | MeSH ID | Detail |
|---|---|---|
| Congenital Hypothyroidism | D003409 | 1 associated lipids |
| Fetomaternal Transfusion | D005331 | 1 associated lipids |
| Sarcoma, Endometrial Stromal | D018203 | 1 associated lipids |
| Prostatic Intraepithelial Neoplasia | D019048 | 1 associated lipids |
| Rhabdomyoma | D012207 | 1 associated lipids |
| Schistosomiasis haematobia | D012553 | 1 associated lipids |
| Granular Cell Tumor | D016586 | 1 associated lipids |
| Angiomyolipoma | D018207 | 1 associated lipids |
| Sertoli Cell Tumor | D012707 | 1 associated lipids |
| Paraganglioma, Extra-Adrenal | D010236 | 1 associated lipids |
HEMATOXYLIN
HEMATOXYLIN is a lipid of Polyketides (PK) class. Hematoxylin is associated with abnormalities such as Eosinophilia, Duodenal Adenoma, Senile Plaques, Morphologically altered structure and Cervical abscess. The involved functions are known as Uptake, Apoptosis, Amplification, Necrosis and Karyopyknosis. Hematoxylin often locates in Body tissue, Extracellular, Compact bone, Skin and Basement membrane. The associated genes with HEMATOXYLIN are GAPDH gene, Genome, Elastin, MERTK wt Allele and P4HTM gene.
Cross Reference
Introduction
To understand associated biological information of HEMATOXYLIN, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with HEMATOXYLIN?
HEMATOXYLIN is suspected in Senile Plaques, Eosinophilia, Duodenal Adenoma, Morphologically altered structure, Cervical abscess and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with HEMATOXYLIN
PubChem Associated disorders and diseases
What pathways are associated with HEMATOXYLIN
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with HEMATOXYLIN?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with HEMATOXYLIN?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with HEMATOXYLIN?
There are no associated biomedical information in the current reference collection.
What genes are associated with HEMATOXYLIN?
Related references are published most in these journals:
- Am. J. Clin. Pathol. (1)
- Am. J. Physiol. Lung Cell Mol. Physiol. (1)
- Ann. Rheum. Dis. (1)
- Others (4)
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with HEMATOXYLIN?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with HEMATOXYLIN
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Lu F et al. | Nuclear ING2 expression is reduced in human cutaneous melanomas. | 2006 | Br. J. Cancer | pmid:16755297 |
| GarcÃa-Closas M et al. | Established breast cancer risk factors by clinically important tumour characteristics. | 2006 | Br. J. Cancer | pmid:16755295 |
| Terry G et al. | The role of human papillomavirus type 16 and the fragile histidine triad gene in the outcome of cervical neoplastic lesions. | 2004 | Br. J. Cancer | pmid:15570308 |
| Hu DE et al. | Early detection of tumour immune-rejection using magnetic resonance imaging. | 2003 | Br. J. Cancer | pmid:12671716 |
| Watson PH et al. | Carbonic anhydrase XII is a marker of good prognosis in invasive breast carcinoma. | 2003 | Br. J. Cancer | pmid:12671706 |
| Aaltonen K et al. | Reliability of cyclin A assessment on tissue microarrays in breast cancer compared to conventional histological slides. | 2006 | Br. J. Cancer | pmid:16670718 |
| Unger K et al. | RET rearrangements in post-Chernobyl papillary thyroid carcinomas with a short latency analysed by interphase FISH. | 2006 | Br. J. Cancer | pmid:16641909 |
| Bocci G et al. | Antiangiogenic and anticolorectal cancer effects of metronomic irinotecan chemotherapy alone and in combination with semaxinib. | 2008 | Br. J. Cancer | pmid:18443598 |
| Varani J et al. | Vascular tube formation on matrix metalloproteinase-1-damaged collagen. | 2008 | Br. J. Cancer | pmid:18443597 |
| Smith SL et al. | S100A2 is strongly expressed in airway basal cells, preneoplastic bronchial lesions and primary non-small cell lung carcinomas. | 2004 | Br. J. Cancer | pmid:15467767 |
| Yokota N et al. | Self-production of tissue factor-coagulation factor VII complex by ovarian cancer cells. | 2009 | Br. J. Cancer | pmid:19904262 |
| Grabowski P et al. | Prognostic value of nuclear survivin expression in oesophageal squamous cell carcinoma. | 2003 | Br. J. Cancer | pmid:12556969 |
| Palfi S et al. | Correlation of in vitro infiltration with glioma histological type in organotypic brain slices. | 2004 | Br. J. Cancer | pmid:15292940 |
| Hibi K et al. | Methylation pattern of CDH13 gene in digestive tract cancers. | 2004 | Br. J. Cancer | pmid:15292927 |
| Rehman I et al. | S100A6 (Calcyclin) is a prostate basal cell marker absent in prostate cancer and its precursors. | 2004 | Br. J. Cancer | pmid:15280928 |
| McFadyen MC et al. | Cytochrome P450 CYP1B1 activity in renal cell carcinoma. | 2004 | Br. J. Cancer | pmid:15280921 |
| Suzuoki M et al. | Impact of caveolin-1 expression on prognosis of pancreatic ductal adenocarcinoma. | 2002 | Br. J. Cancer | pmid:12402154 |
| Kikuchi R et al. | Nuclear BAG-1 expression reflects malignant potential in colorectal carcinomas. | 2002 | Br. J. Cancer | pmid:12402153 |
| Connolly EM et al. | Cyclo-oxygenase inhibition reduces tumour growth and metastasis in an orthotopic model of breast cancer. | 2002 | Br. J. Cancer | pmid:12107848 |
| Anders M et al. | Loss of the coxsackie and adenovirus receptor contributes to gastric cancer progression. | 2009 | Br. J. Cancer | pmid:19142187 |
| Wu X et al. | Hsp90 is expressed and represents a therapeutic target in human oesophageal cancer using the inhibitor 17-allylamino-17-demethoxygeldanamycin. | 2009 | Br. J. Cancer | pmid:19142186 |
| Ino K et al. | Angiotensin II type 1 receptor expression in ovarian cancer and its correlation with tumour angiogenesis and patient survival. | 2006 | Br. J. Cancer | pmid:16434990 |
| Barnes N et al. | Survivin expression in in situ and invasive breast cancer relates to COX-2 expression and DCIS recurrence. | 2006 | Br. J. Cancer | pmid:16421596 |
| Le Page C et al. | Gene expression profiling of primary cultures of ovarian epithelial cells identifies novel molecular classifiers of ovarian cancer. | 2006 | Br. J. Cancer | pmid:16421595 |
| Hiraoka K et al. | Concurrent infiltration by CD8+ T cells and CD4+ T cells is a favourable prognostic factor in non-small-cell lung carcinoma. | 2006 | Br. J. Cancer | pmid:16421594 |
| D'Arcy V et al. | BORIS, a paralogue of the transcription factor, CTCF, is aberrantly expressed in breast tumours. | 2008 | Br. J. Cancer | pmid:18195709 |
| Graf MR et al. | The neuro-steroid, 3beta androstene 17alpha diol exhibits potent cytotoxic effects on human malignant glioma and lymphoma cells through different programmed cell death pathways. | 2007 | Br. J. Cancer | pmid:17637679 |
| Miyazono F et al. | Quantitative c-erbB-2 but not c-erbB-1 mRNA expression is a promising marker to predict minor histopathologic response to neoadjuvant radiochemotherapy in oesophageal cancer. | 2004 | Br. J. Cancer | pmid:15213712 |
| Mathioudaki K et al. | The PRMT1 gene expression pattern in colon cancer. | 2008 | Br. J. Cancer | pmid:19078953 |
| Ebihara Y et al. | DARPP-32 expression arises after a phase of dysplasia in oesophageal squamous cell carcinoma. | 2004 | Br. J. Cancer | pmid:15188007 |
| Julien C et al. | Assessment of vascular reactivity in rat brain glioma by measuring regional blood volume during graded hypoxic hypoxia. | 2004 | Br. J. Cancer | pmid:15188003 |
| Sigstad E et al. | A prospective study of the relationship between prediagnostic human papillomavirus seropositivity and HPV DNA in subsequent cervical carcinomas. | 2002 | Br. J. Cancer | pmid:12107839 |
| Roche-Nagle G et al. | Antimetastatic activity of a cyclooxygenase-2 inhibitor. | 2004 | Br. J. Cancer | pmid:15213717 |
| Chiyomaru T et al. | miR-145 and miR-133a function as tumour suppressors and directly regulate FSCN1 expression in bladder cancer. | 2010 | Br. J. Cancer | pmid:20160723 |
| Barnes NL et al. | Cyclooxygenase-2 inhibition: effects on tumour growth, cell cycling and lymphangiogenesis in a xenograft model of breast cancer. | 2007 | Br. J. Cancer | pmid:17285134 |
| Kaneko K et al. | Study of p53 gene alteration as a biomarker to evaluate the malignant risk of Lugol-unstained lesion with non-dysplasia in the oesophagus. | 2007 | Br. J. Cancer | pmid:17285122 |
| Lin HJ et al. | Elevated phosphorylation and activation of PDK-1/AKT pathway in human breast cancer. | 2005 | Br. J. Cancer | pmid:16288304 |
| Hekmatyar SK et al. | ¹H nuclear magnetic resonance spectroscopy characterisation of metabolic phenotypes in the medulloblastoma of the SMO transgenic mice. | 2010 | Br. J. Cancer | pmid:20842126 |
| Barboro P et al. | Heterogeneous nuclear ribonucleoprotein K: altered pattern of expression associated with diagnosis and prognosis of prostate cancer. | 2009 | Br. J. Cancer | pmid:19401687 |
| Nakayama N et al. | KRAS or BRAF mutation status is a useful predictor of sensitivity to MEK inhibition in ovarian cancer. | 2008 | Br. J. Cancer | pmid:19018267 |
| Bjørge L et al. | Ascitic complement system in ovarian cancer. | 2005 | Br. J. Cancer | pmid:15726105 |
| Yokoyama Y and Ramakrishnan S | Improved biological activity of a mutant endostatin containing a single amino-acid substitution. | 2004 | Br. J. Cancer | pmid:15083196 |
| Frei KA et al. | Photodynamic detection of diseased axillary sentinel lymph node after oral application of aminolevulinic acid in patients with breast cancer. | 2004 | Br. J. Cancer | pmid:14970857 |
| Lau YS et al. | Malignant melanoma and bone resorption. | 2006 | Br. J. Cancer | pmid:16641914 |
| Kato T et al. | Prognostic significance of microvessel density and other variables in Japanese and British patients with primary invasive breast cancer. | 2007 | Br. J. Cancer | pmid:17923874 |
| Al-Yasi AR et al. | Axillary node status in breast cancer patients prior to surgery by imaging with Tc-99m humanised anti-PEM monoclonal antibody, hHMFG1. | 2002 | Br. J. Cancer | pmid:11953817 |
| Otake M et al. | Selective accumulation of ALA-induced PpIX and photodynamic effect in chemically induced hepatocellular carcinoma. | 2003 | Br. J. Cancer | pmid:12915887 |
| Teh SK et al. | Diagnostic potential of near-infrared Raman spectroscopy in the stomach: differentiating dysplasia from normal tissue. | 2008 | Br. J. Cancer | pmid:18195711 |
| Griffiths RW et al. | Expression of the 5T4 oncofoetal antigen in renal cell carcinoma: a potential target for T-cell-based immunotherapy. | 2005 | Br. J. Cancer | pmid:16222313 |
| Koppert LB et al. | Frequent loss of the AXIN1 locus but absence of AXIN1 gene mutations in adenocarcinomas of the gastro-oesophageal junction with nuclear beta-catenin expression. | 2004 | Br. J. Cancer | pmid:14970870 |
| Di Benedetto M et al. | Inhibition of epidermoid carcinoma A431 cell growth and angiogenesis in nude mice by early and late treatment with a novel dextran derivative. | 2003 | Br. J. Cancer | pmid:12799647 |
| Hall JS et al. | Exon-array profiling unlocks clinically and biologically relevant gene signatures from formalin-fixed paraffin-embedded tumour samples. | 2011 | Br. J. Cancer | pmid:21407225 |
| Bing C et al. | Adipose atrophy in cancer cachexia: morphologic and molecular analysis of adipose tissue in tumour-bearing mice. | 2006 | Br. J. Cancer | pmid:17047651 |
| Frost K et al. | Inhibin/activin expression in human and rodent liver: subunits α and βB as new players in human hepatocellular carcinoma? | 2011 | Br. J. Cancer | pmid:21407220 |
| Hao J et al. | Co-expression of CD147 (EMMPRIN), CD44v3-10, MDR1 and monocarboxylate transporters is associated with prostate cancer drug resistance and progression. | 2010 | Br. J. Cancer | pmid:20736947 |
| Graham K et al. | Gene expression in histologically normal epithelium from breast cancer patients and from cancer-free prophylactic mastectomy patients shares a similar profile. | 2010 | Br. J. Cancer | pmid:20197764 |
| Ash S et al. | Immunomodulation with dendritic cells and donor lymphocyte infusion converge to induce graft vs neuroblastoma reactions without GVHD after allogeneic bone marrow transplantation. | 2010 | Br. J. Cancer | pmid:20978501 |
| Terry G et al. | The expression of FHIT, PCNA and EGFR in benign and malignant breast lesions. | 2007 | Br. J. Cancer | pmid:17164758 |
| Kahlert C et al. | Increased expression of ALCAM/CD166 in pancreatic cancer is an independent prognostic marker for poor survival and early tumour relapse. | 2009 | Br. J. Cancer | pmid:19603023 |
| Lee YK et al. | BubR1 as a prognostic marker for recurrence-free survival rates in epithelial ovarian cancers. | 2009 | Br. J. Cancer | pmid:19603021 |
| Chen H et al. | Coexpression of invasive markers (uPA, CD44) and multiple drug-resistance proteins (MDR1, MRP2) is correlated with epithelial ovarian cancer progression. | 2009 | Br. J. Cancer | pmid:19603017 |
| Yoshikawa D et al. | Clinicopathological and prognostic significance of EGFR, VEGF, and HER2 expression in cholangiocarcinoma. | 2008 | Br. J. Cancer | pmid:18087285 |
| Negri FV et al. | Biological predictive factors in rectal cancer treated with preoperative radiotherapy or radiochemotherapy. | 2008 | Br. J. Cancer | pmid:18087284 |
| Ord JJ et al. | Comparison of hypoxia transcriptome in vitro with in vivo gene expression in human bladder cancer. | 2005 | Br. J. Cancer | pmid:16052224 |
| Savic S et al. | Comprehensive epidermal growth factor receptor gene analysis from cytological specimens of non-small-cell lung cancers. | 2008 | Br. J. Cancer | pmid:18087280 |
| Kusakari T et al. | C-erbB-2 or mutant Ha-ras induced malignant transformation of immortalized human ovarian surface epithelial cells in vitro. | 2003 | Br. J. Cancer | pmid:14676809 |
| Mizukami Y et al. | Localisation pattern of Foxp3+ regulatory T cells is associated with clinical behaviour in gastric cancer. | 2008 | Br. J. Cancer | pmid:18087278 |
| Leonard P et al. | Gene expression array profile of human osteosarcoma. | 2003 | Br. J. Cancer | pmid:14676807 |
| Lo Muzio L et al. | Survivin expression in oral squamous cell carcinoma. | 2003 | Br. J. Cancer | pmid:14676801 |
| Wu F et al. | A randomised clinical trial of high-intensity focused ultrasound ablation for the treatment of patients with localised breast cancer. | 2003 | Br. J. Cancer | pmid:14676799 |
| Jamieson SM et al. | Paclitaxel induces nucleolar enlargement in dorsal root ganglion neurons in vivo reducing oxaliplatin toxicity. | 2003 | Br. J. Cancer | pmid:12799641 |
| Hassel JC et al. | MGMT gene promoter methylation correlates with tolerance of temozolomide treatment in melanoma but not with clinical outcome. | 2010 | Br. J. Cancer | pmid:20736948 |
| Dunn J et al. | Extent of MGMT promoter methylation correlates with outcome in glioblastomas given temozolomide and radiotherapy. | 2009 | Br. J. Cancer | pmid:19536096 |
| Siriwardena BS et al. | Periostin is frequently overexpressed and enhances invasion and angiogenesis in oral cancer. | 2006 | Br. J. Cancer | pmid:17060937 |
| Alain T et al. | The oncolytic effect in vivo of reovirus on tumour cells that have survived reovirus cell killing in vitro. | 2006 | Br. J. Cancer | pmid:17047650 |
| Klevesath MB et al. | The value of immunohistochemistry in sentinel lymph node histopathology in breast cancer. | 2005 | Br. J. Cancer | pmid:15942633 |
| Tonini G et al. | Nuclear and cytoplasmic expression of survivin in 67 surgically resected pancreatic cancer patients. | 2005 | Br. J. Cancer | pmid:15928668 |
| Donnelly ET et al. | Metallothionein crypt-restricted immunopositivity indices (MTCRII) correlate with aberrant crypt foci (ACF) in mouse colon. | 2005 | Br. J. Cancer | pmid:15928667 |
| Nakakubo Y et al. | Clinical significance of immune cell infiltration within gallbladder cancer. | 2003 | Br. J. Cancer | pmid:14583778 |
| Doak SH et al. | Characterisation of p53 status at the gene, chromosomal and protein levels in oesophageal adenocarcinoma. | 2003 | Br. J. Cancer | pmid:14583777 |
| Radny P et al. | Phase II trial of intralesional therapy with interleukin-2 in soft-tissue melanoma metastases. | 2003 | Br. J. Cancer | pmid:14583759 |
| Reid AH et al. | Molecular characterisation of ERG, ETV1 and PTEN gene loci identifies patients at low and high risk of death from prostate cancer. | 2010 | Br. J. Cancer | pmid:20104229 |
| Taylor SE et al. | Infrared spectroscopy with multivariate analysis to interrogate endometrial tissue: a novel and objective diagnostic approach. | 2011 | Br. J. Cancer | pmid:21326237 |
| Brown MD et al. | Promotion of prostatic metastatic migration towards human bone marrow stoma by Omega 6 and its inhibition by Omega 3 PUFAs. | 2006 | Br. J. Cancer | pmid:16523199 |
| Harada K et al. | Genetic and epigenetic alterations of Ras signalling pathway in colorectal neoplasia: analysis based on tumour clinicopathological features. | 2007 | Br. J. Cancer | pmid:17923875 |
| Bussolati G et al. | A modified Trastuzumab antibody for the immunohistochemical detection of HER-2 overexpression in breast cancer. | 2005 | Br. J. Cancer | pmid:15812476 |
| Fang DD et al. | Expansion of CD133(+) colon cancer cultures retaining stem cell properties to enable cancer stem cell target discovery. | 2010 | Br. J. Cancer | pmid:20332776 |
| Liu W et al. | Effects of overexpression of ephrin-B2 on tumour growth in human colorectal cancer. | 2004 | Br. J. Cancer | pmid:15083195 |
| Bugat R et al. | Summary of the Standards, Options and Recommendations for the management of patients with carcinoma of unknown primary site (2002). | 2003 | Br. J. Cancer | pmid:12915904 |
| Villers A et al. | Summary of the Standards, Options and Recommendations for the management of patients with nonmetastatic prostate cancer (2001). | 2003 | Br. J. Cancer | pmid:12915903 |
| Tasaki M et al. | ALKBH3, a human AlkB homologue, contributes to cell survival in human non-small-cell lung cancer. | 2011 | Br. J. Cancer | pmid:21285982 |
| Oladipo O et al. | The expression and prognostic impact of CXC-chemokines in stage II and III colorectal cancer epithelial and stromal tissue. | 2011 | Br. J. Cancer | pmid:21285972 |
| Akagi T et al. | Induction of sodium iodide symporter gene and molecular characterisation of HNF3 beta/FoxA2, TTF-1 and C/EBP beta in thyroid carcinoma cells. | 2008 | Br. J. Cancer | pmid:18682709 |
| de Graeff P et al. | Factors influencing p53 expression in ovarian cancer as a biomarker of clinical outcome in multicentre studies. | 2006 | Br. J. Cancer | pmid:16880779 |
| Ieta K et al. | CEACAM6 gene expression in intrahepatic cholangiocarcinoma. | 2006 | Br. J. Cancer | pmid:16868542 |
| Modjtahedi H et al. | Immunohistochemical discrimination of wild-type EGFR from EGFRvIII in fixed tumour specimens using anti-EGFR mAbs ICR9 and ICR10. | 2012 | Br. J. Cancer | pmid:22315050 |
| Kamura S et al. | Basic fibroblast growth factor in the bone microenvironment enhances cell motility and invasion of Ewing's sarcoma family of tumours by activating the FGFR1-PI3K-Rac1 pathway. | 2010 | Br. J. Cancer | pmid:20606682 |
| Kato T et al. | The combination of angiogenesis and blood vessel invasion as a prognostic indicator in primary breast cancer. | 2003 | Br. J. Cancer | pmid:12799634 |
| Kettunen E et al. | DNA copy number loss and allelic imbalance at 2p16 in lung cancer associated with asbestos exposure. | 2009 | Br. J. Cancer | pmid:19337251 |
| Gisselsson D et al. | Centrosomal abnormalities, multipolar mitoses, and chromosomal instability in head and neck tumours with dysfunctional telomeres. | 2002 | Br. J. Cancer | pmid:12107843 |